Smithsonian Magazine on MSN8d
This 17-Year-Old Scientist Is Making an Acetaminophen Alternative That Is Less Damaging to the Liver
Chloe Yehwon Lee’s research could change the painkiller, known by the brand name Tylenol, for the better, ultimately reducing ...
Sarepta’s stock slammed after patient dies of liver failure. Here’s what Wall Street is saying.
based Sarepta said in a statement. “Acute liver failure leading to death represents a severity of acute liver injury not previously reported for Elevidys, which to date has been used to treat more ...
Knowridge Science Report1d
Consider your liver: Here’s how it protects your health
“The liver is important for maintaining the health of the overall body, because it processes all the nutrients from the food ...
Sarepta Therapeutics Stock Falls as Some Trials Halted After Patient Death
Key Takeaways Some studies of Sarepta Therapeutics' muscular dystrophy drug, Elevidys, have been halted by European ...
Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...
MedPage Today19d
Young Patient Dies After Receiving New Gene Therapy for Duchenne Muscular Dystrophy
acute liver failure leading to death represents a severity of acute liver injury not previously reported for Elevidys, which to date has been used to treat more than 800 patients in clinical ...
Rheumatology Advisor10d
Patient Dies Following Treatment With DMD Gene Therapy Elevidys
Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.
Sarepta falls after notifying of patient death following treatment with Elevidys
Therapeutics are down 24.95, or 25%, to $76.40 in pre-market trading after the company shared a safety update related ...
MedCity News18d
Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys
The patient, a young man, suffered acute liver failure after receiving the therapy, Sarepta said. Liver injury is a known complication risk of Elevidys and other gene therapies that use an adeno ...
Fierce Pharma2d
UPDATE: After patient death, Sarepta and Roche pause 3 trials of gene therapy Elevidys in Europe
In response to a request from the European Medicines Agency (EMA) following the death of a 16-year-old patient in the U.S., ...
Monthly Prescribing Reference18d
Patient Dies Following Treatment With DMD Gene Therapy Elevidys
The patient in this case had suffered acute liver failure following the Elevidys infusion. While acute serious liver injury has been observed with Elevidys and is listed as a warning in the ...